Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D gene

By Tachedjian M.   Krywult J.   Moore R.J.   Hodgson A.L.M.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1785-1792

Elsevier

Access to resources Recommend Favorite

Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D

By Hodgson A.L.M.   Carter K.   Tachedjian M.   Krywult J.   Corner L.A.   McColl M.   Cameron A.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 802-808

Elsevier

Access to resources Recommend Favorite

Use of a rationally attenuated Bordetella bronchiseptica as a live mucosal vaccine and vector for heterologous antigens

By Stevenson A.   Roberts M.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2325-2335

Elsevier

Access to resources Recommend Favorite

Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: An observation with Escherichia coli -galactosidase in Mycobacterium smegmatis and its implication in vaccine development

By Kumar D.   Srivastava B.S.   Srivastava R.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1212-1215

Elsevier

Access to resources Recommend Favorite

Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus

By Hayney M.S.   Poland G.A.   Dimanlig P.   Schaid D.J.   Jacobson R.M.   Lipsky J.J.  

Vaccine, Vol. 15, Iss. 1, 1997-01 ,pp. : 3-6

Elsevier

Access to resources Recommend Favorite